Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tail
about
The immunological synapse: the gateway to the HIV reservoirImpact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backboneHigh-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entryWhich Antibody Functions are Important for an HIV Vaccine?P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.Unique features of HIV-1 spread through T cell virological synapses.Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-DependentHIV-1 vaginal transmission: cell-free or cell-associated virus?The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell TransmissionThe membrane proximal external regions of gp41 from HIV-1 strains HXB2 and JRFL have different sensitivities to alanine mutation.The frantic play of the concealed HIV envelope cytoplasmic tail.The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells.Unique functional properties of conserved arginine residues in the lentivirus lytic peptide domains of the C-terminal tail of HIV-1 gp41.Mechanisms of enhanced HIV spread through T-cell virological synapses.HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapyReduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.Broadly neutralizing antibodies: An approach to control HIV-1 infection.Dense Array of Spikes on HIV-1 Virion Particles.Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosisThe pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus.New Connections: Cell-to-Cell HIV-1 Transmission, Resistance to Broadly Neutralizing Antibodies, and an Envelope Sorting Motif.Measuring T Cell-to-T Cell HIV-1 Transfer, Viral Fusion, and Infection Using Flow Cytometry.Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes.HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail.Non-Neutralizing Antibodies Directed against HIV and Their Functions.Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation.HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
P2860
Q27002959-8B2E059A-209F-4ED8-AEF4-A99EC0C8762DQ28535477-93F32F8B-B60C-439A-B3AB-3006D341B196Q30570557-DE7BEB35-9245-42FB-9B82-AFC5D8BEFE9AQ30810565-338E836B-94AB-478A-847C-2B909E109923Q33772637-B488442A-5005-4ACD-BA35-428AB3CCAED0Q34261784-25EE5DBD-3118-4C79-B4BA-E9FF1475F76BQ35529719-163842C7-CAF4-4B6F-ACBA-BCB9808E508FQ35686912-CF977139-5CC9-471D-AD39-C8568585623CQ35897398-35170383-696A-4DFD-8E94-410777A2A321Q36123960-11CBE41F-FA49-4506-9DC6-C6C20CEBB13BQ36384607-E0AFBF80-84BA-4A20-8527-E219BAEC6E62Q36940646-FE4AAD1B-9F3E-4B44-BB89-11616683D4CCQ37415455-F8F310B3-F4C9-4110-AA55-94B14751FFECQ37425205-77179B05-1756-453E-A065-6529993239A8Q37635804-E6430091-1787-4523-BC35-228A271B0F78Q38070789-BAF61B0F-A341-4ED4-93B1-28F443A01240Q38376002-04E451F1-8D28-499B-A154-8B0EA2570586Q38718435-7C63258B-C4DB-4E1B-9232-E0636D3816B5Q38811735-61DB856E-3825-4B45-9B5D-EAC561B944B6Q38817990-4289E4DB-755D-40E0-BA88-F74A26544C90Q39470792-550CF1AB-0E2B-4F7D-8904-729C65AC1A06Q40190061-224765D9-C42A-4844-8C81-60C4009556D7Q40312301-AA3BAFC9-D4FC-44BB-BB7E-19868682AC4AQ40852789-5093BD5D-1B88-477D-B13D-F20A92E33815Q41102793-A622CD74-CDE4-4999-A045-7735FD137699Q41127118-4D7D3C1F-E768-41E6-A451-D9F241D00040Q47139556-168A0682-C27D-4FA8-802A-8136F01CEFD7Q47548910-95AB6C73-0934-481B-A016-A430055BF68FQ49900491-D4076FFC-3B51-4173-8ED7-7414499DB8DBQ57030223-0315B63B-2C6D-4EFA-9DBB-5AE0ECB4CB3D
P2860
Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tail
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Neutralization resistance of v ...... d by the gp41 cytoplasmic tail
@ast
Neutralization resistance of v ...... d by the gp41 cytoplasmic tail
@en
type
label
Neutralization resistance of v ...... d by the gp41 cytoplasmic tail
@ast
Neutralization resistance of v ...... d by the gp41 cytoplasmic tail
@en
prefLabel
Neutralization resistance of v ...... d by the gp41 cytoplasmic tail
@ast
Neutralization resistance of v ...... d by the gp41 cytoplasmic tail
@en
P2093
P2860
P356
P1433
P1476
Neutralization resistance of v ...... d by the gp41 cytoplasmic tail
@en
P2093
Alice W Yewdall
Benjamin K Chen
Chati Zony
James E Robinson
Natasha D Durham
Rebecca Lee
P2860
P304
P356
10.1128/JVI.00230-12
P577
2012-05-02T00:00:00Z